IV
IV company profile
Latest price
As of — · Market data by Massive
Market cap
—
Volume
—
Previous close
—
Day range
—
Listed
—
Coverage
12 articles
Price performance
Recent trading
Newsroom
Latest IV coverage
New technologies and medications that can prevent, reduce CVD top 2023 scientific research
[ad_1] (NewMediaWire) – December 19, 2023 – DALLAS — Technologies that less invasively restore blood flow to blocked or narrowed arteries; a medicine that outsmarts high blood pressure’s development; and new evidence that diabetes drugs may offer heart health benefits to people that don’t have diabetes are among the news-making scientific researc
Semaglutide Injections, IV Hydration, and the Visionaries at Drip Docx: Navigating the Next Generation of Wellness
[ad_1] Alexandria, VA – (NewMediaWire) – September 25, 2023 – As the health and wellness industry evolves, cutting-edge treatments like Semaglutide injections for weight loss and personalized IV hydration therapies are coming to the fore. Pioneering this wave of innovation is Drip Docx, a concierge medical spa that seamlessly merges health,
Gallus Medical Detox Unveils Pioneering Detox Program for Pregnant Women
[ad_1] DENVER, CO – (NewMediaWire) – July 25, 2023 – Gallus Medical Detox Centers, a leading provider of medically supervised detoxification services, is thrilled to announce the launch of a groundbreaking program designed to provide safe, effective, and compassionate drug and alcohol detox for pregnant women. This innovative program signif
Can Regenerative Medicine Winter Park Make All the Difference? QC Kinetix (Winter Park) Answers
[ad_1] Winter Park, FL – (NewMediaWire) – January 20, 2023 – via QC Kinetix – Joint pain has become a common health complaint among young and old adults. This problem could be traced to various causes, from lifestyle choices to occupation, age, genetics, and more. Despite the growing frequency of the problem, traditional medicine is f
Intravenous iron improved long-term outcomes for people with heart failure and iron deficiency
[ad_1] Research Highlights: Repeated intravenous (IV) administration of iron reduced the risk of hospitalization for heart failure and cardiovascular death in people with heart failure and iron deficiency, according to a clinical trial in the United Kingdom. Treatment with IV iron was safe and well-tolerated, and people who received it reported improve
NewMediaWire | Modafinil Online Demand Rises on the Tide
[ad_1] TULSA, OK – (NewMediaWire) – September 14, 2022 – The Health industry too has tapped into the potential of online spree to keep up with the demand. These off-prescription drugs that are not so easily available over the counter help drive the demand for them via online mode. One such drug is Modafinil – ...
Vision Sensing Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option
[ad_1] Miami, FL – (NewMediaWire) – November 03, 2021 – Vision Sensing Acquisition Corp. (the “Company”), a newly incorporated blank check company, today announced the closing of its initial public offering of 10,120,000 units, including 1,320,000 units issued pursuant to the underwriters’ full exercise of the over-allot
CannaCard Announces Rolling Tour 2021
[ad_1] CannaCard® is Rolling Through Illinois and Missouri Visiting Dispensaries From August 16-24, 2021 Chicago, Illinois – (NewMediaWire) – August 05, 2021 – CannaTrac® Technology, Inc. (“CannaTrac” or “the Company”), the leading cashless payment solution for the cannabis industries, announced today its Rolling Tour where the team will be
Neovasc Announces First Patient Enrollment in COSIMA Trial
[ad_1] VANCOUVER and MINNEAPOLIS – (NewMediaWire) – May 10, 2021 – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the first patient has been enrolled in the COronarySInus Reducer for the Treatment of Refractory MicrovascularAngina (“COSIMA”) trial. The enrollment occurred at University Hospital, Mainz, Ge
Neovasc Comments on Journal of the American Heart Association Publication
[ad_1] VANCOUVER and MINNEAPOLIS – (NewMediaWire) – February 05, 2021 – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the Journal of the American Heart Association has published an article entitled, “Angina Severity, Mortality, and Healthcare Utilization Among Veterans with Stable Angina”. The prestigio
Combo therapy may prevent blood vessel complications in children with Kawasaki disease
[ad_1] Research Highlights: For children with Kawasaki disease with higher risk of developing blood vessel complications, adding corticosteroids to standard intravenous immunoglobulin treatment could boost initial treatment response and prevent complications. Researchers used real-world data from large, nationwide Japanese Kawasaki disease surveys to c
Currency Market Outlook: Dump The Dollar
[ad_1] We are presenting our 2019 Market Outlook in 4 elements: I. 2018 Market Review and Economic Outlook II. Bond & Yield Outlook III. Currency and Commodity Forecasts (under) IV. Equity Market Strategy for 2019 (forthcoming) Currency Market Outlook This part of our 2019 Outlook presents our forex market outlook. In sum, we're bearish on ...